Insider Holders & Insider Ownership - LEXICON PHARMACEUTICALS INC. (LXRX)

List of insiders holdings for LEXICON PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 Invus Public Equities L.P.
Artal Treasury Ltd
Invus L.P.
Invus Public Equities Advisors LLC
Invus Advisors L.L.C.
Director
10% Owner		 2024-12-09 21:33:20 136,180,481
0		 136,180,481 Form 13D
2 Artal International S.C.A.
Wittouck Amaury
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Invus Public Equities L.P.
Invus L.P.
Invus Public Equities Advisors LLC
Invus Advisors L.L.C.
Director
10% Owner		 2024-12-09 21:33:20 136,180,481
0		 136,180,481 Form 13D
3 Artal Participations S.a r.l.
Director
10% Owner		 2024-12-16 19:00:08 136,180,481
0		 136,180,481 Form 3
4 Artal International S.C.A.
Minne Pascal
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Director
10% Owner		 2020-12-17 14:43:18 0
71,178,364		 71,178,364 Form 4
5 Siren L.L.C.
Invus Global Management LLC
Director
10% Owner		 2024-07-29 17:31:42 0
38,918,903		 38,918,903 Form 3
6 MCNAIR ROBERT C
10% Owner		 2003-08-08 16:21:09 5,949,400
0		 5,949,400 Form 13D
7 Invus US Partners LLC
Ulys L.L.C.
DEBBANE RAYMOND
Director
10% Owner		 2022-08-09 16:48:13 331,545
5,451,204		 5,782,749 Form 4
8 Invus C.V.
Director
10% Owner		 2021-01-05 21:21:12 4,321,214
0		 4,321,214 Form 4
9 Exton Michael
Chief Executive Officer		 2025-02-18 16:16:42 3,774,480
0		 3,774,480 Form 4
10 SANDS ARTHUR T
President & CEO		 2014-03-03 18:20:20 1,236,579
877,500		 2,114,079 Form 4
11 COATS LONNEL
Chief Executive Officer		 2024-02-29 16:26:53 1,430,198
0		 1,430,198 Form 4
12 Coiante Scott M
SVP, Chief Financial Officer		 2025-02-18 16:17:54 1,201,780
0		 1,201,780 Form 4
13 Corrigan Brian
SVP, Regulatory & QA		 2025-02-18 16:18:38 1,121,660
0		 1,121,660 Form 4
14 MAIN ALAN J
EVP, Innov & Chem Sciences		 2025-03-03 16:32:25 508,494
0		 508,494 Form 4
15 Garner Thomas
SVP, Chief Commercial Officer		 2024-02-12 16:14:04 454,260
0		 454,260 Form 4
16 Crum Brian T
SVP, General Counsel & Secr.		 2025-03-03 16:28:42 433,045
0		 433,045 Form 4
17 ZAMBROWICZ BRIAN P
EVP, Chief Scientific Officer		 2014-03-03 18:16:40 402,953
0		 402,953 Form 4
18 WADE JEFFREY L
President and COO		 2024-07-08 17:27:46 307,000
0		 307,000 Form 4
19 Granowitz Craig B
SVP, Chief Medical Officer		 2025-03-03 16:31:11 304,495
0		 304,495 Form 4
20 Kassler-Taub Kenneth B.
SVP, Regulatory & QA		 2024-02-29 16:29:48 255,742
0		 255,742 Form 4
21 McDermott Wendy
SVP, Human Resources		 2025-03-03 16:33:08 253,976
0		 253,976 Form 4
22 BROWN PHILIP M
SVP, Clinical Development		 2010-02-17 17:12:29 253,606
0		 253,606 Form 4
23 BANSAL AJAY
EVP Corp Dev and CFO		 2009-06-02 17:44:48 250,000
0		 250,000 Form 4
24 TYLE PRAVEEN
EVP, R&D		 2021-03-02 17:00:45 204,771
0		 204,771 Form 4
25 RIGGS RANDALL B
SVP, Corp Licensing		 2004-02-25 16:13:19 192,500
0		 192,500 Form 4
26 Cheung Ivan
Director		 2024-12-02 17:41:59 186,685
0		 186,685 Form 4
27 GREGORY JULIA P
EVP and CFO		 2008-02-11 18:05:27 150,000
0		 150,000 Form 4
28 Alexander Kristen
VP, Finance and Accounting		 2025-03-03 16:33:57 132,068
0		 132,068 Form 4
29 Tessmer James F
VP, Finance & Accounting		 2021-03-16 19:45:56 122,746
0		 122,746 Form 4
30 Seth Kiernan
VP, Chief Commercial Officer		 2023-03-01 16:55:29 104,350
0		 104,350 Form 4
31 HOWSON TAMAR D
EVP of Bus Dev		 2008-02-11 18:05:30 100,000
0		 100,000 Form 4
32 Lapuerta Pablo
EVP and CMO		 2020-04-24 17:02:57 85,719
0		 85,719 Form 4
33 Tragash Steven Alan
VP, Corporate Affairs		 2010-02-17 18:06:17 85,500
0		 85,500 Form 4
34 LEFKOWITZ ROBERT J MD
Director		 2024-05-13 16:03:08 81,716
0		 81,716 Form 4
35 Swain Judith L
Director		 2024-05-13 16:05:26 81,716
0		 81,716 Form 4
36 Sullivan Diane E.
Director		 2024-05-13 16:04:41 81,716
0		 81,716 Form 4
37 SOBECKI CHRISTOPHER J
Director		 2024-05-13 16:03:48 81,716
0		 81,716 Form 4
38 DEBBANE RAYMOND
Director		 2024-05-13 16:02:19 81,716
0		 81,716 Form 4
39 BARKER SAM L
Director		 2024-05-13 16:01:32 81,716
0		 81,716 Form 4
40 Amouyal Philippe
Director		 2024-05-13 16:00:44 81,716
0		 81,716 Form 4
41 ISHIMOTO LANCE K
SVP, Intellectual Property		 2008-02-11 18:05:33 80,000
0		 80,000 Form 4
42 PERSON CHRISTOPHE
VP Informatics		 2004-01-13 17:01:48 75,900
0		 75,900 Form 4
43 DeFrancesco Lisa
SVP, IR and Corp Comm		 2025-03-03 16:30:24 64,924
0		 64,924 Form 4
44 SCHAFER CAROL
VP Finance - Communications		 2003-12-10 15:01:46 61,000
0		 61,000 Form 3
45 Santini Alexander A
EVP and CCO		 2020-04-24 17:12:22 55,584
0		 55,584 Form 4
46 PIGGOTT JAMES R PHD
SVP of Pharm Bio		 2008-02-11 18:05:40 50,000
0		 50,000 Form 4
47 NORTHCOTT JOHN
VP, Marketing, Comm Strategy		 2015-03-03 16:08:14 41,985
0		 41,985 Form 4
48 NIES ALAN S
Director		 2023-05-22 16:05:20 41,046
0		 41,046 Form 4
49 Palantoni Frank
Director		 2023-05-22 16:06:07 40,332
0		 40,332 Form 4
50 COLBERT WALTER F
SVP, HR and Corp Serv		 2007-02-15 16:40:13 40,000
0		 40,000 Form 4
51 ROSE CLAYTON STUART
Director		 2007-06-27 16:34:13 25,000
0		 25,000 Form 4
52 Mills Barry
Director		 2007-04-27 16:35:38 10,000
0		 10,000 Form 4
53 Wiltsey Kathleen M
Director		 2009-04-27 16:40:25 10,000
0		 10,000 Form 4
54 CLOHERTY PATRICIA M
Director		 2006-04-28 17:58:27 10,000
0		 10,000 Form 4
55 CASKEY C THOMAS
Director		 2005-10-17 17:52:09 6,300
200		 6,500 Form 4